Kiniksa Pharmaceuticals L... (KNSA)
22.41
-0.68 (-2.94%)
At close: Mar 31, 2025, 10:34 AM
Kiniksa Pharmaceuticals Ltd. Cash Flow Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -43.19M | 14.08M | 183.36M | -157.92M | -161.38M | -161.87M | -103.23M | -64.87M | -23.97M |
Depreciation & Amortization | 1.7M | 2.34M | 2.4M | 2.35M | 2.4M | 2.07M | 286K | 28K | 22K |
Stock-Based Compensation | 30.69M | 27.15M | 25.12M | 25.17M | 20.88M | 15.08M | 5.7M | 897K | 368K |
Other Working Capital | 46.81M | 11.48M | -2.01M | 6.91M | 654K | -12.32M | 9.51M | 12.92M | 1.64M |
Other Non-Cash Items | 3.55M | 2.17M | 2.99M | 3.4M | 1.52M | 6.53M | -1.12M | -53K | 293K |
Deferred Income Tax | 8.13M | -33.79M | -185.5M | 11K | 4.36M | -3.16M | -978K | -197K | -46K |
Change in Working Capital | 24.81M | 1.35M | -22.57M | 689K | -4.32M | -17.02M | 18.33M | 13.93M | 1.76M |
Operating Cash Flow | 25.69M | 13.3M | 5.81M | -126.3M | -136.53M | -158.37M | -81.01M | -50.22M | -21.87M |
Capital Expenditures | -277K | -130K | -105K | -20.41M | -283K | -3.2M | -5.29M | -69K | -3K |
Acquisitions | n/a | n/a | 91K | 20M | 23.16M | -52.42M | n/a | n/a | n/a |
Purchase of Investments | -202.01M | -204.93M | -135.86M | -157.25M | -430.21M | -488.77M | -402.01M | n/a | n/a |
Sales Maturities Of Investments | 239.94M | 175.51M | 127.8M | 306.3M | 407.05M | 541.19M | 168.1M | n/a | n/a |
Other Investing Acitivies | 25K | n/a | -7.97M | -20M | -23.16M | 52.42M | -233.91M | n/a | n/a |
Investing Cash Flow | 37.67M | -29.56M | -8.08M | 128.63M | -23.44M | 49.21M | -239.2M | -69K | -3K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -4.98M | -2.21M | -901K | 5.88M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 17.25M | 3.7M | 3.42M | 5.88M | -1.14M | 1M | 187.54M | 39.87M | 42.51M |
Financial Cash Flow | 12.27M | 1.5M | 2.52M | 5.88M | 227.09M | 84.11M | 346.74M | 39.87M | 42.51M |
Net Cash Flow | 75.63M | -14.76M | 245K | 8.22M | 67.11M | -25.05M | 26.53M | -10.41M | 20.64M |
Free Cash Flow | 25.41M | 13.17M | 5.7M | -146.71M | -136.81M | -161.57M | -86.3M | -50.29M | -21.87M |